Lonza Announce New Drug Product Manufacturing Services in Guangzhou,China

摘要

The global manufacturing partner to the pharma,biotech and nutrition industries,Lonza,have announced a new drug product fill and finish manufacturing line will be installed at its Guangzhou(CN)site.Hong Pan,General Manager,China,Lonza,commented:"The investment in drug product manufacturing capabilities at Lonza Guangzhou not only demonstrates our commitment to the Chinese market but also marks an important milestone in achieving our long-term ambition of increasing drug product capacity and addreBing growing customer demand for an end-to-end drug product solution.Through the expansion of our services at Lonza Guangzhou,we will have the capability to support our customers with the late-stage clinical trial and commercial development of potentially life-saving treatments."The new investment will fund the installation of an aseptic drug product fill and finish production line at the 17,000 m~2 state-of-the-art cGMP mammalian facility.The Guangzhou(CN)facility began operations in Q2 2021 and expects to deliver its first cGMP batch later this year.